WinstonWınston
Accendra Health logo

Accendra Health

ACH
21
Medical - Distribution · Healthcare
Price
$3.47
-0.31 (-8.20%)
Market Cap
$265.7M
Winston Score
21
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+1.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 75.5M (2021) → 76.9M (2025)

Accendra Health is a healthcare distribution company that moves medical supplies and pharmaceutical products from manufacturers to hospitals, clinics, and other healthcare providers. It acts as a middleman in the medical supply chain, making sure the right products reach the right facilities when they are needed.

The company earns revenue by buying products in bulk and reselling them at a markup, a model common across medical distribution. With a market cap of roughly $200 million, Accendra is a small player in a sector dominated by much larger distributors like McKesson and Cardinal Health, which gives those giants significant pricing and scale advantages. The main risk for Accendra is margin pressure, since its operating margin is already thin at 3.5%, leaving little room for error if customers push for lower prices or if supply chain costs rise.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-73.7% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+81.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

26.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$282M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Accendra Health's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
40.9%
Healthy — 40.9% gross margin
Operating Margin
3.1%
Thin — 3.1% operating margin
ROCE
1.3%
Weak — 1.3% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-29.1%
Shrinking sales (-29.1% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-6.5%
Burning cash (-6.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
0.07x
Dangerous — barely covers interest (0.1x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial